KDM1A and neoplasm: Here we replicated doses of LSD1 inhibitors we previously characterized to induce NK reactivity in pediatric brain tumors without exerting direct tumor cytotoxicity, as a model of co-administration, and measured viability using amine-reactive dyes and flow cytometry.